Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAMK1D | Q8IU85 | 20/20 | 1.00 |
| ▸ | PIP5K1C | O60331 | 1/20 | 0.82 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.82 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.82 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.82 |
| ▸ | MAP2K5 | Q13163 | 1/20 | 0.82 |
| ▸ | CAMK1 | Q14012 | 1/20 | 0.82 |
| ▸ | MAP3K11 | Q16584 | 1/20 | 0.82 |
| ▸ | PNCK | Q6P2M8 | 1/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23113390 | 1.00 | CAMK1D (1.00) | CAMK1DPIP5K1CCYP2C9CYP2C19KCNH2 | |
| SCHEMBL23113712 | 1.00 | CAMK1D (1.00) | CAMK1DPIP5K1CCYP2C9CYP2C19KCNH2 | |
| SCHEMBL23113574 | 0.96 | CAMK1D (1.00) | CAMK1DPIP5K1CCYP2C9CYP2C19KCNH2 | |
| SCHEMBL23113576 | 0.96 | CAMK1D (1.00) | CAMK1DPIP5K1CCYP2C9CYP2C19KCNH2 | |
| SCHEMBL28498475 | 0.94 | CAMK1D (1.00) | CAMK1DPIP5K1CCYP2C9CYP2C19KCNH2 | |
| SCHEMBL24735851 | 0.94 | CAMK1D (1.00) | CAMK1DPIP5K1CCYP2C9CYP2C19KCNH2 | |
| SCHEMBL23113639 | 0.93 | CAMK1D (1.00) | CAMK1DPIP5K1CCYP2C9CYP2C19KCNH2 | |
| SCHEMBL23113640 | 0.93 | CAMK1D (1.00) | CAMK1DPIP5K1CCYP2C9CYP2C19KCNH2 | |
| SCHEMBL23113520 | 0.93 | CAMK1D (1.00) | CAMK1DPIP5K1CCYP2C9CYP2C19KCNH2 | |
| SCHEMBL23113519 | 0.93 | CAMK1D (1.00) | CAMK1DPIP5K1CCYP2C9CYP2C19KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11530193-B2 | Kinase inhibitors | THE UNIVERSITY OF MANCHESTER (GB) | 2022-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11530193-B2 | Kinase inhibitors | CAMKK2, CAMK1, CAMKK1 | CAMK1D 5/4885PIP5K1C 232/4885CYP2C9 4177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.